Thyroid Disease Associated With Exposure to the Nevada Nuclear Weapons Test Site Radiation: A Reevaluation Based on Corrected Dosimetry and Examination Data

Background: A study was begun in 1965 to 1966 to determine whether children exposed to radioactive iodine from nuclear weapons testing at the Nevada Test Site from 1951 through 1962 were at higher risk of thyroid disease. In 1993, we reported that among those examined in 1985 to 1986 (Phase II) there was an association between radiation from the Nevada Test Site and thyroid neoplasms. Methods: We reevaluated the relationship between exposure to Nevada Test Site fallout and thyroid disease using newly corrected dose estimates and disease outcomes from the Phase II study. A prospective cohort of school children 12 to 18 years old living in Utah, Nevada, and Arizona was first examined for thyroid disease in 1965 to 1966 and reexamined in 1985 to 1986. In the Phase II report, 2497 subjects formed the basis for this analysis. Thyroid disease, including thyroid neoplasms and thyroiditis, was expressed as cumulative incidence and risk ratios (RRs) with a dose–response expressed as excess risk ratio (ERR/Gy). Results: The RR between thyroid radiation dose in the highest dose group and thyroid neoplasms increased from 3.4 (in the earlier analysis) to 7.5. The RR for thyroiditis increased from 1.1 to 2.7 with an ERR/Gy of 4.9 (95% confidence interval = 2.0 to 10.0). There were too few malignant thyroid neoplasms to estimate risk. Conclusions: Persons exposed to radioactive iodine as children have an increased risk of thyroid neoplasms and autoimmune thyroiditis up to 30 years after exposure.

[1]  Raymond J. Carroll,et al.  Measurement error in nonlinear models: a modern perspective , 2006 .

[2]  J. Fraumeni,et al.  Radiation carcinogenesis: Epidemiology and biological significance , 1984 .

[3]  J. Boice Radiation-induced thyroid cancer--what's new? , 2005, Journal of the National Cancer Institute.

[4]  Whicker Fw,et al.  Pathway: a dynamic food-chain model to predict radionuclide ingestion after fallout deposition. , 1987 .

[5]  A. Pinchera,et al.  Post-Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and France. , 1997, The Journal of clinical endocrinology and metabolism.

[6]  Katsumi Eguchi,et al.  Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure. , 2006, JAMA.

[7]  A. Bouville,et al.  TRANSFER OF 131I INTO HUMAN BREAST MILK AND TRANSFER COEFFICIENTS FOR RADIOLOGICAL DOSE ASSESSMENTS , 2002, Health physics.

[8]  L. Holm,et al.  Hypothyroidism following 131I therapy for hyperthyroidism in relation to immunologic parameters. , 1980, Acta radiologica. Oncology.

[9]  R. D. Lloyd,et al.  The Utah Thyroid Cohort Study: analysis of the dosimetry results. , 1995, Health physics.

[10]  F W Whicker,et al.  Pathway: a dynamic food-chain model to predict radionuclide ingestion after fallout deposition. , 1987, Health physics.

[11]  C. Eheman,et al.  Autoimmune thyroid disease associated with environmental thyroidal irradiation. , 2003, Thyroid : official journal of the American Thyroid Association.

[12]  O. P. Schumacher,et al.  Long-term follow-up results in children and adolescents treated with radioactive iodine (131I) for hyperthyroidism. , 1975, The New England journal of medicine.

[13]  F. Trimarchi,et al.  Post-Chernobyl increased prevalence of humoral thyroid autoimmunity in children and adolescents from a moderately iodine-deficient area in Russia. , 1999, Thyroid : official journal of the American Thyroid Association.

[14]  R. E. Olsen,et al.  Surgically treated thyroid disease among young people in Utah, 1948-1962. , 1967, American journal of public health and the nation's health.

[15]  L. Holm,et al.  Malignant Thyroid Tumors after Iodine-131 Therapy , 1980 .

[16]  Division on Earth Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2 , 2006 .

[17]  Elisabeth Cardis,et al.  Risk of thyroid cancer after exposure to 131I in childhood. , 2005, Journal of the National Cancer Institute.

[18]  F. O. Hoffman,et al.  Semiparametric Regression Modeling with Mixtures of Berkson and Classical Error, with Application to Fallout from the Nevada Test Site , 2002, Biometrics.

[19]  K. Kopecky,et al.  Risk of Thyroid Cancer in the Bryansk Oblast of the Russian Federation after the Chernobyl Power Station Accident , 2004, Radiation research.

[20]  Scott Davis,et al.  Thyroid neoplasia, autoimmune thyroiditis, and hypothyroidism in persons exposed to iodine 131 from the hanford nuclear site. , 2004, JAMA.

[21]  F. O. Hoffman,et al.  2004 Update of Dosimetry for the Utah Thyroid Cohort Study , 2006, Radiation research.

[22]  R. D. Lloyd,et al.  Development of a method to estimate thyroid dose from fallout radioiodine in a cohort study. , 1990, Health physics.

[23]  A. McTiernan,et al.  Incidence of thyroid cancer in women in relation to reproductive and hormonal factors. , 1984, American journal of epidemiology.

[24]  D. Hall Measurement Error in Nonlinear Models: A Modern Perspective , 2008 .

[25]  S. Nagataki,et al.  Thyroid diseases among atomic bomb survivors in Nagasaki. , 1994, JAMA.

[26]  R. D. Lloyd,et al.  A cohort study of thyroid disease in relation to fallout from nuclear weapons testing. , 1993, JAMA.